- Biotech – CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration to develop gene-edited therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia
- Buzz off – A study published in the Proceedings of the National Academy of Sciences documents the first use of CRISPER/Cas9 gene editing to target a specific gene tied to fertility in male mosquitoes.
Chen, J. et al. (2021) Suppression of female fertility in Aedes aegypti with a CRISPR-targeted male-sterile mutation. Proceedings of the National Academy of Sciences DOI: 10.1073/pnas.2105075118
- CRISPR-based detection of SARS-CoV-2 -Scientists have developed a CRISPR-based lab-on-paper device for detection of SARS-CoV-2.
Yin, K. et al. (2021) Autonomous lab-on-paper for multiplexed, CRISPR-based diagnostics of SARS-CoV-2. Lab on a Chip. https://doi.org/10.1039/D1LC00293G
- UK eases restrictions on gene editing – In a break with restrictive EU regulations on gene-editing rules, the UK is making it easier to genetically modify plants and animals with precision techniques such as CRISPR. https://science.sciencemag.org/content/372/6545/895?rss=1